[EN] ALPHA-(TRIFLUOROMETHYL-SUBSTITUTED ARYLOXY, ARYLAMINO, ARYLTHIO OR ARYLMETHYL)-TRIFLUOROMETHYL-SUBSTITUTED PHENYLACETIC ACIDS AND DERIVATIVES AS ANTIDIABETIC AGENTS [FR] UTILISATION D'ACIDES PHENYLACETIQUES SUBSTITUES PAR ALPHA-(ARYLOXY, ARYLAMINO, ARYLTHIO OU ARYLMETHYLE SUBSTITUE PAR TRIFLUOROMETHYLE)-TRIFLUOROMETHYLE ET DE LEURS DERIVES EN TANT QU'AGENTS ANTIDIABETIQUES
[EN] ALPHA-(TRIFLUOROMETHYL-SUBSTITUTED ARYLOXY, ARYLAMINO, ARYLTHIO OR ARYLMETHYL)-TRIFLUOROMETHYL-SUBSTITUTED PHENYLACETIC ACIDS AND DERIVATIVES AS ANTIDIABETIC AGENTS [FR] UTILISATION D'ACIDES PHENYLACETIQUES SUBSTITUES PAR ALPHA-(ARYLOXY, ARYLAMINO, ARYLTHIO OU ARYLMETHYLE SUBSTITUE PAR TRIFLUOROMETHYLE)-TRIFLUOROMETHYLE ET DE LEURS DERIVES EN TANT QU'AGENTS ANTIDIABETIQUES
Cycloalkylidene Compounds as Selective Estrogen Receptor Modulators
申请人:Fang Jing
公开号:US20080167360A1
公开(公告)日:2008-07-10
The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation.
Alpha(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
申请人:Zhao Zuchun
公开号:US20050222213A1
公开(公告)日:2005-10-06
Compounds having a formula:
or a pharmaceutically acceptable salt or prodrug thereof, are provided, and are useful for the treatment of metabolic disorders.
提供具有以下公式的化合物:或其药物可接受的盐或前药,可用于治疗代谢性疾病。
ALPHA-(TRIFLUOROMETHYL-SUBSTITUTED ARYLOXY, ARYLAMINO, ARYLTHIO OR ARYLMETHYL)-TRIFLUOROMETHYL-SUBSTITUTED PHENYLACETIC ACIDS AND DERIVATIVES AS ANTIDIABETIC AGENTS
申请人:Zhao Zuchun
公开号:US20080287441A1
公开(公告)日:2008-11-20
Compounds having a formula:
or a pharmaceutically acceptable salt or prodrug thereof, are provided, and are useful for the treatment of metabolic disorders.
提供一种具有以下公式的化合物,或其药学上可接受的盐或前药,它们有助于治疗代谢性疾病。
α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
申请人:Metabolex, Inc.
公开号:US07371888B2
公开(公告)日:2008-05-13
Compounds having a formula:
or a pharmaceutically acceptable salt or prodrug thereof, are provided, and are useful for the treatment of metabolic disorders.